Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey

被引:56
|
作者
Kehey, Amy S. [1 ]
Reid, M. Carrington [2 ]
Miller, David H. [3 ]
Fins, Joseph J. [4 ]
Lachs, Mark S. [2 ]
机构
[1] Univ Calif Los Angeles, Div Gen Internal Med, Los Angeles, CA USA
[2] Cornell Univ, Weill Med Coll, Div Geriatr & Gerontol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA
[4] Cornell Univ, Weill Med Coll, Div Med Eth, New York, NY 10021 USA
关键词
QUALITY-OF-LIFE; CONGESTIVE-HEART-FAILURE; RECIPIENTS; COMPLICATIONS; DECISIONS; PACEMAKER; VIGNETTES; MANAGEMENT; FREQUENCY; DISEASE;
D O I
10.1016/j.ahj.2008.12.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Among older adults, implantable cardioverter-defibrillator (ICD) use is increasing. ICD shocks can occur at end of life (EOL) and cause substantial distress, warranting consideration of ICD deactivation discussions. This nationwide physician survey sought to (1) determine if physicians discuss ICD deactivation at the EOL, (2) identify predictors of those discussions, and (3) ascertain physicians' knowledge/attitudes about ICD use. Methods We surveyed 4,876 physicians stratified by specialty (cardiologists, electrophysiologists, general internists, and geriatricians). The mailed survey presented 5 vignettes leg, end-stage chronic obstructive pulmonary disease, advanced dementia) wherein ICD deactivation might be considered and 17 Likert-scaled items. Results Five hundred fifty-eight (12%) physicians returned surveys. Respondents were largely men (77%) and white (69%). Most physicians (56%-83%) said they would initiate deactivation discussions in all 5 vignettes, whereas significantly more (82%-94%) would discuss advance directives and do not resuscitate status. In logistic regression analyses, a history of prior deactivation discussions was an independent predictor of willingness to discuss deactivation (adjusted OR range, 2.8-8.8) in 4 of the 5 vignettes. General internists and geriatricians were less likely than electrophysiologists. to agree that ICD shocks are painful and to distinguish between the ICD's pacing and defibrillator functions. Finally, most physicians believed that informed consent for ICD implantation should include information about deactivation (77%) and endorsed the need for expert guidance in this area (58%). Conclusions Most physicians would discuss ICD deactivation at EOL. The strongest predictor of this was a history of prior discussions. Knowledge about ICDs varies by specialty, and most expressed a desire for more expert guidance about ICD management at EOL. (Am Heart J 2009; 157:702-8.)
引用
收藏
页码:702 / 708
页数:7
相关论文
共 50 条
  • [21] Implantable cardioverter-defibrillator shocks
    Raitt, Merritt H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) : 1366 - 1368
  • [22] Development of the Implantable Cardioverter-Defibrillator
    Maron, Barry J.
    Estes, N. A. Mark
    Rowin, Ethan J.
    Maron, Martin S.
    Reynolds, Matthew R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (04) : 353 - 373
  • [23] THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - AN UPDATE
    MIROWSKI, M
    JOURNAL OF CARDIOVASCULAR MEDICINE, 1984, 9 (03): : 191 - &
  • [24] The subcutaneous implantable cardioverter-defibrillator
    Grace, Andrew
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 10 - 19
  • [25] An Irish cross sectional survey of patients knowledge of implantable cardioverter defibrillator (ICD) and their deactivation at end of life.
    Mcdermott, E.
    Mooney, M.
    Odonnell, S.
    Mckee, G.
    Obrien, F.
    Ryan, P.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2018, 17 : 75 - 76
  • [26] A prophylactic implantable cardioverter-defibrillator?
    Brugada, P
    Wellens, F
    Andries, E
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 128 - 133
  • [27] Implantable cardioverter-defibrillator advances
    Lerman, RD
    Cannom, DS
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (01) : 16 - 22
  • [28] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    LATTUCA, J
    VELTRI, EP
    AMERICAN HEART JOURNAL, 1989, 118 (06) : 1359 - 1359
  • [29] "Real life" longevity of implantable cardioverter-defibrillator devices
    Manolis, Antonis S.
    Maounis, Themistoklis
    Koulouris, Spyridon
    Vassilikos, Vassilios
    CLINICAL CARDIOLOGY, 2017, 40 (09) : 759 - 764
  • [30] Indications for implantable Cardioverter-Defibrillator
    Tebbenjohanns, J
    Niehaus, M
    Korte, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (41) : 2120 - 2124